Financials
Income statement
Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
---|---|---|---|---|
Total reported revenue | 12.3B | 11.2B | 13.9B | 12.0B |
Cost of revenue | 8.5B | 7.9B | 9.7B | 8.2B |
Gross profit | 3.8B | 3.3B | 4.2B | 3.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 2.4B | 2.2B | 2.7B | 2.3B |
Other operating expenses | — | — | — | — |
Operating income | 1.4B | 1.1B | 1.6B | 1.4B |
Non operating interest income | ||||
Income | 38.3M | 40.9M | 50.2M | 53.6M |
Expense | 15.3M | 15.3M | 14.5M | 17.0M |
Other income expense | — | — | — | — |
Pretax income | 1.4B | 1.1B | 1.6B | 1.5B |
Tax provision | 344.0M | 264.0M | 418.1M | 373.8M |
Net income | 1.1B | 882.2M | 1.2B | 1.1B |
Basic EPS | 1.1 | 0.9 | 1.2 | 1.1 |
Diluted EPS | 1.1 | 0.9 | 1.2 | 1.1 |
Basic average shares | 947.5M | 950.1M | 953.1M | 957.4M |
Diluted average shares | 960.5M | 963.9M | 969.0M | 971.6M |
EBITDA | 1.7B | 1.4B | 1.9B | 1.7B |
Net income from continuing op. | 1.1B | 882.2M | 1.2B | 1.1B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |